Pro-Rose Plus
Commercial- Indications
- Cancer prevention, General health maintenance
Company intelligence / Profile preview
Bard Cancer Diagnostics is a specialized medical facility in New York City focused on advanced, non-invasive cancer imaging and early detection. Founded by Dr. Robert L. Bard, the center utilizes cutting-edge technologies such as 3D/4D Doppler ultrasound, elastography, and MRI to provide high-resolution analysis of tumors in the prostate, breast, skin, and thyroid. By focusing on blood flow (angiogenesis) and tissue stiffness, the practice offers "digital biopsy" alternatives to traditional invasive procedures. Bard Cancer Diagnostics is recognized for its expertise in monitoring treatment efficacy and its commitment to personalized cancer prevention and functional health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bard Cancer Diagnostics.